Price target upside
Orchestra BioMed Holdings, Inc. - Ordinary Shares Price Target Upside or Downside
OBIO price target upside based on the current price and analyst average.
Direct answer
Orchestra BioMed Holdings, Inc. - Ordinary Shares's analyst target implies +179%.
The average target is $12.33 compared with a recorded current price of $4.42.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 12, 2026.
Get free Orchestra BioMed Holdings, Inc. - Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.42
- Average price target
- $12.33
- High price target
- $20.00
- Low price target
- $9.00
- Target upside
- +179%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026